We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Woodcock Rebuffs Proposed ‘Firewall’ Between FDA Staff Following Aducanumab Dispute
Woodcock Rebuffs Proposed ‘Firewall’ Between FDA Staff Following Aducanumab Dispute
Acting FDA Commissioner Janet Woodcock rejected a proposal to put up a “firewall” between FDA staff involved in pre-submission interactions and staff working on post-submission drug and biologic reviews and decisions, defending the agency’s collaboration with sponsors as critical to the development process.